Melandrium firmum rohrbach extract may be the latest miracle-worker, with death-defying health benefits—cell death-defying, that is. This South Korean patent application explores its role for cosmetics and more.
Melandrium firmum rohrbach to inhibit cellular senescence
WIPO Patent Application WO/2016/047823
Publication date: March 31, 2016
Assignee: Research Cooperation Foundation of Yeungnam University
This invention relates to a composition for inhibiting cellular senescence that contains a Melandrium firmum Rohrbach extract or (-)-bornesitol derived from it. According to the inventors, applications include treating skin aging, rheumatoid arthritis, osteoarthritis, arteriosclerosis, prostatic hyperplasia, liver cancer, etc.
The invention also is expected to be used to develop anti-aging functional foods, anti-vascular aging drugs, and cosmetics that may inhibit cellular senescence. Additional details were not disclosed.
Patent application accessed April 5, 2016.